How the European in vitro diagnostic regulation could negatively impact the European response to the next pandemic: an urgent call for action before May 2022
- PMID: 33979703
- PMCID: PMC8106968
- DOI: 10.1016/j.cmi.2021.05.009
How the European in vitro diagnostic regulation could negatively impact the European response to the next pandemic: an urgent call for action before May 2022
Keywords: COVID-19 testing; Diagnostic test approval; Europe; IVD; IVDR; In vitro diagnostic regulation; Lab-developed test; Medical device legislation.
Similar articles
-
Pathology in the legal framework of European and German medical device law: Operation, use and in-house manufacture of in vitro diagnostic medical devices.Ger Med Sci. 2024 Oct 11;22:Doc09. doi: 10.3205/000335. eCollection 2024. Ger Med Sci. 2024. PMID: 39559338 Free PMC article. Review.
-
Medical Device Regulation: A Comparison of the United States and the European Union.J Am Acad Orthop Surg. 2016 Aug;24(8):537-43. doi: 10.5435/JAAOS-D-15-00403. J Am Acad Orthop Surg. 2016. PMID: 27195383
-
Complex analytical procedures in diagnostic laboratories and the IVDR.Clin Chem Lab Med. 2020 Dec 11;59(3):457-458. doi: 10.1515/cclm-2020-1775. Clin Chem Lab Med. 2020. PMID: 33554564 No abstract available.
-
Easing Medical Device Regulatory Oversight: The FDA and Testing Amidst the COVID-19 Pandemic.Am J Law Med. 2021 Jul;47(2-3):291-326. doi: 10.1017/amj.2021.18. Am J Law Med. 2021. PMID: 34405782
-
Implementation of the new EUR IVD regulation and relation with ISO15189 accreditation: Guidance is urgently required for haemostasis testing.Int J Lab Hematol. 2022 Sep;44 Suppl 1:71-78. doi: 10.1111/ijlh.13936. Int J Lab Hematol. 2022. PMID: 36074714 Review.
Cited by
-
SARS-CoV-2 Diagnostics Based on Nucleic Acids Amplification: From Fundamental Concepts to Applications and Beyond.Front Cell Infect Microbiol. 2022 Mar 23;12:799678. doi: 10.3389/fcimb.2022.799678. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35402302 Free PMC article. Review.
-
Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid and antibody tests up to 22 August 2020.Euro Surveill. 2021 Nov;26(45):2001675. doi: 10.2807/1560-7917.ES.2021.26.45.2001675. Euro Surveill. 2021. PMID: 34763752 Free PMC article.
-
Socioeconomic impact of artificial intelligence-driven point-of-care testing devices for liquid biopsy in the OncoCheck system.Cancer Metastasis Rev. 2025 Aug 6;44(3):64. doi: 10.1007/s10555-025-10281-3. Cancer Metastasis Rev. 2025. PMID: 40764849 Free PMC article. Review.
References
-
- Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing directive 98/79/EC and Commission Decision 2010/227/EU. https://eur-lex.europa.eu/eli/reg/2017/746/oj Available from:
-
- van Drongelen A., de Bruijn A., Pennings J., van der Maaden T. RIVM Letter Report 2018-0082; 2018. The impact of the new European IVD classification rules on the notified body involvement. A study on the IVDs registered in the Netherlands.
-
- Vermeersch P., van Aelst T., Dequeker E.M. The new IVD Regulation 2017/746: a case study at a large university hospital laboratory in Belgium demonstrates the need for clarification on the degrees of freedom laboratories have to use lab-developed tests to improve patient care. Clin Chem Lab Med. 2020;59:101–106. - PubMed
-
- Reusken B.E.M., Broberg E.K., Haagmans B., Meijer A., Corman V.M., Papa A. Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020. Euro Surveill. 2020;25:2000082. doi: 10.2807/1560-7917.ES.2020.25.6.2000082. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous